Most Read Articles
11 Jul 2015
The 3-month formulation of paliperidone palmitate (PP) effectively reduced relapse rates in schizophrenia patients in a 12-week open-label multicentre trial. [ICOSR 2015, Abstract 2087240; JAMA Psychiatry 2015, doi:10.1001/jamapsychiatry.2015.0241]
02 May 2018
At a recent Lundbeck Neuroscience Symposium at Hilton Kota Kinabalu, Professor Bernhard Baune discussed important clinical considerations in the management of behavioural and psychological symptoms of dementia (BPSD), focussing on the role of memantine hydrochloride (Ebixa®; Lundbeck).
03 May 2018
In community-dwelling elderly adults, a decline in will to live (WTL) predicts depressive symptoms (DS) rather than vice versa, a recent Israel study has shown.
12 Jan 2017
Adding increased activity or energy as part of DSM-5 criterion A reduces the prevalence of manic and hypomanic episodes, a new study suggests. However, the new criterion does not affect longitudinal clinical outcomes.

Optimal and sustainable management of schizophrenia and bipolar disorder improves the well-being of patients

04 May 2018
Scientists unveiled genetics behind schizophrenia that may provide new clues on treating the disease
Globally, one in four people will be affected by psychiatric or neurological disorders during their lifetime.With an estimated affected population of 450 million people, mental disorders are among the leading causes of ill-health and disability worldwide.At the recent Lundbeck Neuroscience Symposium held at Hilton Kota Kinabalu from 3–5 November 2017, three renowned key opinion leaders from the field of psychiatry shared their insights into the optimal management of bipolar disorder and schizophrenia.

Related MIMS Drugs

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Psychiatry - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
11 Jul 2015
The 3-month formulation of paliperidone palmitate (PP) effectively reduced relapse rates in schizophrenia patients in a 12-week open-label multicentre trial. [ICOSR 2015, Abstract 2087240; JAMA Psychiatry 2015, doi:10.1001/jamapsychiatry.2015.0241]
02 May 2018
At a recent Lundbeck Neuroscience Symposium at Hilton Kota Kinabalu, Professor Bernhard Baune discussed important clinical considerations in the management of behavioural and psychological symptoms of dementia (BPSD), focussing on the role of memantine hydrochloride (Ebixa®; Lundbeck).
03 May 2018
In community-dwelling elderly adults, a decline in will to live (WTL) predicts depressive symptoms (DS) rather than vice versa, a recent Israel study has shown.
12 Jan 2017
Adding increased activity or energy as part of DSM-5 criterion A reduces the prevalence of manic and hypomanic episodes, a new study suggests. However, the new criterion does not affect longitudinal clinical outcomes.